ERBB2 (HER2), a receptor tyrosine kinase frequently dysregulated in breast and other cancers, also appears as a DDR1 interactor, suggesting a possible cooperative role between DDR1 and RTKs in promoting tumor cell proliferation and survival. This evidence concerns the gene NTRK1 and neoplasm.